CA Stock MarketDetailed Quotes
PHRX Pharmadrug Inc
- 0.010
- 0.0000.00%
15min DelayTrading Aug 16 11:02 ET
1.07MMarket Cap-43P/E (TTM)
0.010High0.010Low42.00KVolume0.010Open0.010Pre Close420.00Turnover0.07552wk High0.04%Turnover Ratio106.73MShares0.00552wk Low-0.229EPS TTM1.07MFloat Cap28.000Historical HighLossP/E (Static)106.66MShs Float0.005Historical Low-0.234EPS LYR0.00%Amplitude--Dividend TTM-0.77P/B1Lot Size--Div YieldTTM
Pharmadrug Inc Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -57.49%-204.77K | -489.36%-543.75K | 65.51%-671.88K | -100.50%-15.97K | 93.90%-200.86K | 73.45%-130.02K | 91.03%-92.26K | 34.43%-1.95M | 644.77%3.17M | -403.12%-3.29M |
| Net income from continuing operations | 65.71%-144.02K | -202.70%-541.15K | -332.83%-13.26M | -625.81%-12.36M | 89.70%-300.01K | 52.77%-419.98K | 88.93%-178.77K | 28.48%-3.06M | 301.05%2.35M | -203.45%-2.91M |
| Operating gains losses | ---- | ---- | 129.72%160.65K | -194.35%-16.57K | 108.80%49.11K | --71.76K | --56.35K | 40.14%-540.59K | --17.56K | ---558.15K |
| Depreciation and amortization | --12.56K | --12.56K | 24.67%26.22K | 407.66%26.22K | --0 | --0 | --0 | 31.28%21.03K | -553.49%-8.52K | 2.04%5.71K |
| Asset impairment expenditure | ---- | ---- | --11.12M | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Unrealized gains and losses of investment securities | --0 | --0 | -120.67%-122.27K | -92.81%16.39K | -82.62%23.15K | -103.34%-2.96K | -212.20%-158.84K | -63.51%591.47K | -44.80%227.99K | -28.27%133.2K |
| Remuneration paid in stock | --47.23K | ---- | 404.92%1.74M | --1.74M | --0 | --0 | ---- | -42.52%344.76K | --0 | -98.04%2.22K |
| Deferred tax | ---- | ---- | -431.76%-1.01M | ---- | ---- | ---- | ---- | ---190K | ---- | ---- |
| Other non cashItems | -8.69%82.16K | 5.77%92.46K | 89.90%384.33K | 110.55%180.05K | -23.60%26.89K | 119.39%89.97K | 155.22%87.42K | 79.26%202.39K | 800.51%85.51K | 4.15%35.2K |
| Change In working capital | -254.52%-202.7K | -205.95%-107.63K | -57.21%294.04K | ---- | ---- | -47.47%131.18K | 52.78%101.58K | 615.98%687.22K | ---- | ---- |
| -Change in receivables | 225.38%4.84K | -441.78%-46.67K | 106.66%3.78K | ---- | ---- | 97.14%-3.86K | 260.43%13.65K | -193.84%-56.68K | ---- | ---- |
| -Change in inventory | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 2,808.36%73.41K | ---- | ---- |
| -Change in prepaid assets | -1,196.49%-50K | --0 | -70.25%8.68K | ---- | ---- | -92.58%4.56K | 115.57%4.56K | 243.68%29.17K | ---- | ---- |
| -Change in payables and accrued expense | -220.74%-157.54K | -173.12%-60.96K | -38.46%351.58K | ---- | ---- | -53.75%130.49K | -18.35%83.37K | 424.96%571.32K | ---- | ---- |
| -Change in other working capital | ---- | ---- | -200.00%-70K | ---- | ---- | ---- | ---- | --70K | ---- | ---- |
| Cash from discontinued investing activities | 0 | 73.28%-309.34K | ||||||||
| Operating cash flow | -57.49%-204.77K | -489.36%-543.75K | 70.23%-671.88K | -100.56%-15.97K | 93.90%-200.86K | 78.99%-130.02K | 92.63%-92.26K | 45.33%-2.26M | 352.57%2.86M | -285.12%-3.29M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 1,114.75%995.04K | 686.69%741.24K | 131.76%8.04K | 37.83K | 207.92K | -94.62%81.91K | 153.08%94.22K | 104.04%3.47K |
| Net business purchase and sale | ---- | ---- | 6,197.21%741.54K | 500,942.57%741.54K | --0 | ---- | ---- | -103.93%-12.16K | 14,900.00%148 | 106.56%3.47K |
| Net investment purchase and sale | --0 | --0 | 169.46%253.5K | -100.32%-300 | --8.04K | --37.83K | --207.92K | -92.25%94.08K | 9,407,400.00%94.08K | --0 |
| Cash from discontinued investing activities | 0 | 0 | 0 | 89.85%-4.34K | 0 | 0 | ||||
| Investing cash flow | --0 | --0 | 1,182.65%995.04K | 686.69%741.24K | 131.76%8.04K | 1,472.29%37.83K | 13,267.95%207.92K | -94.76%77.58K | 2,056.46%94.22K | 104.00%3.47K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | 379.73%326K | -74.40%225.51K | -75.86%93.15K | -3,546.43%-116.54K | 4.74%880.87K | ||||
| Net issuance payments of debt | --0 | --0 | -99.34%4K | ---- | ---- | 6,566.67%100K | -2,903.75%-96K | --601.8K | ---- | ---- |
| Net common stock issuance | --0 | --326K | --0 | ---- | ---- | --0 | --0 | --280K | ---- | ---- |
| Cash dividends paid | --0 | --0 | --0 | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Proceeds from stock option exercised by employees | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -88.89%106K | ---- | ---- |
| Interest paid (cash flow from financing activities) | --0 | --0 | -100.19%-78.49K | ---- | ---- | ---6.85K | ---20.54K | 65.29%-39.21K | ---- | ---- |
| Net other financing activities | ---- | ---- | 542.97%300K | ---- | ---- | ---- | ---- | ---67.72K | ---- | ---- |
| Cash from discontinued financing activities | 0 | 41.24%-37.63K | ||||||||
| Financing cash flow | --0 | 379.73%326K | -73.26%225.51K | ---- | ---- | -74.18%93.15K | -612.26%-116.54K | 8.53%843.25K | ---- | ---- |
| Net cash flow | ||||||||||
| Beginning cash position | 3,994.93%342.38K | 6,447.39%560.13K | -99.12%8.41K | 474.15%160.1K | -48.54%9.92K | -89.18%8.36K | -99.11%8.56K | -55.13%957.98K | -98.40%27.88K | -99.34%19.28K |
| Current changes in cash | -21,408.01%-204.77K | -24,644.55%-217.75K | 141.06%548.67K | 1,157.09%399.41K | -39.99%149.18K | 100.37%961 | 99.93%-880 | 28.57%-1.34M | 96.72%-37.78K | 123.24%248.61K |
| Effect of exchange rate changes | --0 | --0 | -99.21%3.05K | -95.81%773 | 100.41%993 | -99.73%601 | -99.82%686 | -44.25%386.91K | -94.91%18.46K | -190.64%-240.01K |
| Cash adjustments other than cash changes | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 |
| End cash Position | 1,286.75%137.61K | 3,994.93%342.38K | 6,447.39%560.13K | 6,447.39%560.13K | 474.15%160.1K | -48.54%9.92K | -89.18%8.36K | -99.11%8.56K | -99.11%8.56K | -98.40%27.88K |
| Free cash from | -57.49%-204.77K | -489.36%-543.75K | 70.23%-671.88K | -100.56%-15.97K | 93.90%-200.86K | 78.99%-130.02K | 92.63%-92.26K | 45.33%-2.26M | 361.15%2.86M | -270.77%-3.29M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg